| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.076 | 0.2 |